{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:59:28Z","timestamp":1782233968127,"version":"3.54.5"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To examine the incidence of lower genital tract dysplasia in women after solid organ transplantation, to evaluate risk factors associated with development of dysplasia, and to assess the timeline of disease development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>This was a retrospective study of female patients who underwent solid organ transplantation at a large-volume tertiary care center between 2000 and 2015. Demographic and clinicopathologic factors were extracted from electronic medical records. Cumulative incidence of lower genital tract dysplasia was calculated, and univariate and multivariable logistic regression were performed to identify risk factors for the development of dysplasia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Among 394 female solid organ transplant recipients, the median age was 41 years (interquartile range 29\u201353). Forty-seven (11.9%; 95% CI 8.8\u201315.9%) women developed lower genital tract dysplasia over a median follow-up of 7.8 years (interquartile range 4.6\u201312.9). Thirty-eight (9.6%) developed cervical intraepithelial neoplasia (CIN), with 14 (3.6%) diagnosed with CIN 2 or worse (one was cervical carcinoma). Nineteen (4.8%) developed noncervical lower genital tract dysplasia, including vulvar, vaginal, or anal dysplasia, with 13 (3.3%) diagnosed with high-grade dysplasia or worse (five were lower genital tract carcinoma [three anal, one vulvar, and one vaginal]). Ten (2.5%) developed both cervical and noncervical lower genital tract dysplasia. Black race was significantly associated with developing dysplasia (odds ratio [OR] 2.86; 95% CI 1.33\u20136.13) as was hydroxychloroquine use (OR 5.95; 95% CI 1.96\u201318.09). High-grade cervical dysplasia was diagnosed at a median interval of 3.18 years after transplant; noncervical high-grade lower genital tract dysplasia was diagnosed at a median interval of 3.94 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>One in eight transplant recipients developed lower genital tract dysplasia and approximately half were high-grade dysplasia or cancer. Black race and hydroxychloroquine use were associated with an increased risk of dysplasia. Yearly cervical screening and comprehensive lower genital examination beyond the cervix is indicated in this population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000003378","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T12:11:54Z","timestamp":1563192714000},"page":"385-394","source":"Crossref","is-referenced-by-count":10,"title":["Lower Genital Tract Dysplasia in Female Solid Organ Transplant Recipients"],"prefix":"10.1097","volume":"134","author":[{"given":"Matthew A.","family":"Thimm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne F.","family":"Rositch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"VandenBussche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Garonzik Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Levinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"a015677","DOI":"10.1101\/cshperspect.a015677","article-title":"Cancer in the transplant recipient","volume":"3","author":"Chapman","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1743-422X-9-117","article-title":"Prevalence of high-risk human papillomavirus cervical infection in female kidney graft recipients: an observational study","volume":"9","author":"Pietrzak","year":"2012","journal-title":"Virol J"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/AOG.0b013e31819bd6e0","article-title":"Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors","volume":"113","author":"Smith","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/ijc.24215","article-title":"Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions","volume":"124","author":"Hoots","year":"2009","journal-title":"Int J Cancer"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/LGT.0000000000000343","article-title":"Risks of CIN2+, CIN3+, and cancer by cytology and human papillomavirus status: the foundation of risk-based cervical screening guidelines","volume":"21","author":"Demarco","year":"2018","journal-title":"J Low Genit Tract Dis"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/01.AOG.0000210268.57527.a1","article-title":"Trends in the incidence of invasive and in situ vulvar carcinoma","volume":"107","author":"Judson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/ajt.12472","article-title":"HPV-related cancers after solid organ transplantation in the US","volume":"13","author":"Madeleine","year":"2013","journal-title":"Am J Transpl"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/TP.0b013e3181fbd008","article-title":"Skin cancer and (pre)malignancies of the female genital tract in renal transplant recipients","volume":"91","author":"Meeuwis","year":"2011","journal-title":"Transplantation"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/aogs.12663","article-title":"Prevalence of genital dysplasia after kidney transplantation\u2014a retrospective, non-interventional study from two centers","volume":"94","author":"Marschalek","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"e12714","DOI":"10.1111\/tid.12714","article-title":"Relationship between the risk factors for human papillomavirus infection and lower genital tract precursor lesion and cancer development in female transplant recipients","volume":"19","author":"De Oliveria Martins","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"R17-20230711","first-page":"92","article-title":"Cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant recipients","volume":"38","author":"Seshadri","year":"2001","journal-title":"Indian J Cancer"},{"key":"R18-20230711","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2008.05.074","article-title":"Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients","volume":"40","author":"Paternoster","year":"2008","journal-title":"Transplant Proc"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1471-0528.1995.tb09027.x","article-title":"The incidence of cervical intraepithelial neoplasia among women with renal transplant in relation to cyclosporine","volume":"102","author":"Haar-Van Eck","year":"1995","journal-title":"Br J Obstet Gynecol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmj.298.6667.153","article-title":"Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts","volume":"298","author":"Alloub","year":"1989","journal-title":"BMJ"},{"key":"R21-20230711","first-page":"1","article-title":"Human immunodeficiency virus (HIV)\u2013 and non-HIV\u2013associated immunosuppression and risk of cervical neoplasia","volume":"0","author":"Silverberg","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/bjs.1800810313","article-title":"Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients","volume":"81","author":"Ogunbiyi","year":"1994","journal-title":"Br J Surg"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/S0041-1345(01)02202-3","article-title":"Uterine cervical intraepithelial neoplasia in renal transplantation","volume":"33","author":"Ghazizadeh","year":"2001","journal-title":"Transplant Proc"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"656","DOI":"10.12659\/AOT.884029","article-title":"Prevalence of cervical high-risk human papillomavirus infections in kidney graft recipients","volume":"18","author":"Mazanowska","year":"2013","journal-title":"Ann Transpl"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0272-6386(99)70397-5","article-title":"Racial disparities in renal transplant outcomes","volume":"34","author":"Isaacs","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jamcollsurg.2007.01.024","article-title":"Racial disparities in renal allograft survival: a public health issue?","volume":"204","author":"Eckhoff","year":"2007","journal-title":"J Am Coll Surg"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R29-20230711","first-page":"751853","article-title":"Predisposition to cervical atypia in systemic lupus Erythematous: a clinical and cytopathological study","volume":"2015","author":"Al-Sherbeni","year":"2015","journal-title":"Autoimmune Dis"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.22667","article-title":"High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients","volume":"57","author":"Nath","year":"2007","journal-title":"Arthritis Care Res"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"e000156","DOI":"10.1136\/lupus-2016-000156","article-title":"Standardized incidence ratios (SIRs) for cancer after renal transplants in systemic lupus erythematosus (SLE) and non-SLE recipients","volume":"3","author":"Ramsey-Goldman","year":"2016","journal-title":"Lupus Sci Med"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"R34-20230711","first-page":"e111","article-title":"Cervical cancer screening and prevention. Practice Bulletin No. 168. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.transproceed.2009.03.015","article-title":"Surveillance of human papilloma virus infection and cervical cancer in kidney transplant recipients: preliminary data","volume":"41","author":"Veroux","year":"2009","journal-title":"Transpl Proc"},{"key":"R36-20230711","first-page":"647","article-title":"The Uptake of cervical cancer screening by renal transplant recipients","volume":"24","author":"Courtney","year":"2009","journal-title":"NDT"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201908000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:09:11Z","timestamp":1689102551000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201908000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003378","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}